Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company specializing in innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), has announced its participation in Citi's 2025 Virtual Oncology Leadership Summit. Bill Lundberg, M.D., President and Chief Executive Officer of Merus, will deliver a presentation on Thursday, February 20, 2025, at 9:00 a.m. ET.

The presentation will be accessible via webcast on the Investors section of the company's website both during and after the event for a time.

02/13/2025 - 08:00 AM

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will present at Citi's 2025 Virtual Oncology Leadership Summit on Thursday, February 20, 2025 at 9:00 a.m. ET.

The webcast of the presentation will be contemporaneously available on the Investors page of the Company's website. The archived presentation will also be available there for a limited time after the event.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website and LinkedIn.

Multiclonics®, Biclonics® and Triclonics® are registered trademarks of Merus N.V.

FAQ

When is Merus (MRUS) presenting at Citi's 2025 Virtual Oncology Leadership Summit?

Merus (MRUS) will present at Citi's 2025 Virtual Oncology Leadership Summit on Thursday, February 20, 2025, at 9:00 a.m. ET.

How can investors watch Merus's (MRUS) presentation at the Citi Oncology Summit 2025?

Investors can watch the presentation via webcast on the Investors page of Merus's company website. The presentation will also be archived and available for a time after the event.